|
New Tech to Better Measure Pain Medication Adherence
Drug Discovery & Development
July 8, 2010
Patient pain medication monitoring has taken a big step forward with new measuring technology developed by two Marshfield Clinic pain specialists.
The new technology will allow clinicians to measure pain medication adherence with greater certainty and to determine the likelihood that a patient is taking more or less drug than is prescribed.
The technology developed by Michael Larson, Ph.D., a Pain / Clinical Psychologist, and Thomas Richards, D.O., FAAO, of the Neuromusculoskeletal/Osteopathic Manipulative Medicine Department was patented by Marshfield Clinic and has been licensed to Baltimore, Maryland-based Ameritox, the nation?s leader in pain medication monitoring. Ameritox will further develop the technology for potential commercialization as well as support research and development to further expand the scope of the technology and its usability in pain medication monitoring.
Continue Reading...
Share This!
|
